Now Crowd-Source Funds For Organ Transplant

IMT News Desk
IMT News Desk
· 2 min read
mental health

Help the Poor Foundation, a Mumbai-based NGO that has been working towards assisting the lesser privileged in having equal access to organ transplantation today announced its association with Asia’s most visited online crowd funding platform Ketto. Transplants, through its programme JEET (Joint Effort to Enable Transplants), along with Ketto aims to crowd-source funds for those who are in dire need for organ transplant, and cannot afford it.

India has, historically, had a very low rate of organ donation. Although this number has improved over the past three-four years, the gap is very wide. As per most recent reports, more than 20,000 individuals are in need of liver transplants in the country. However, less than 5% of these receive a liver before it is too late, with over 80% receiving a liver from a living related donor. The requirement for liver, kidney and hearttransplants stands at threelakh annually, of which only around 8,000 manage to receive a transplant, with almost 90 percent receiving a living donor transplant. For patients waiting for a heart cut out and lung transplant, the chances of finding an organ is very small, at around 5 percent or even less.

Prof (Dr) Darius Mirza, MS, FRCS and Co-founder of Transplants – Help the poor Foundation, expressing his joy, said: “We are glad that Ketto has stepped forward to support this worthy cause. In the case of organ donation, awareness is as important as donation. So, Ketto is actually helping us twice over. And, I am confident that this association will help to attain equal access to organ transplantation through funds collected from the public and corporates. Awareness about the extent of the problem will also bridge the gap between demand and availability of donated organs for transplants.”

Also, speaking on this association, Mr. Varun Sheth – Co-Founder & CEO, Ketto, said: We are thrilled that our platform is able to partner with an inspiring NGO who is involved in such noble work. We are confident of being able to leverage our credibility among the financially sound to convince them to give open-heartedly, as also using out wide network of supporters to raise awareness about the problem of organ shortage among the people who matter. We look forward to collaborating with Transplants – Help the Poor Foundation, and being a part of this great cause.

Read Next

India successfully validates the first indigenous HPV test for Cervical Cancer screening
News
June 13, 2026

India successfully validates the first indigenous HPV test for Cervical Cancer screening

India has achieved a significant milestone in cervical cancer prevention with the successful validation of the country’s first indigenous HPV DNA tests, which meet international standards for cervical cancer screening. Published in the International Journal of Cancer, a multicentre study involving leading Indian and international institutions found that Molbio Diagnostics Truenat HPV-HR Plus met the […]
Article by: IMT News Desk
Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris
News
June 12, 2026

Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris

Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd., has announced the launch of Winlevi® (clascoterone 10 mg/g cream) across key markets in Europe. This follows the grant of marketing authorization of the product for the treatment of acne vulgaris in both adults and adolescents aged 12 to <18 years (with usage in […]
Article by: IMT News Desk
Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory
News
June 12, 2026

Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory

Thyrocare Technologies Limited has announced the set-up of its new diagnostic laboratory in Prayagraj, Uttar Pradesh, in association with SecondMedic. The new laboratory is equipped with advanced testing infrastructure and supported by trained professionals, enabling timely and error-free diagnostic results. It caters to both specialised and routine testing requirements, offering support to ongoing and preventive […]
Article by: IMT News Desk
AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer
News
June 12, 2026

AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer

AstraZeneca Pharma India Ltd. (AZPIL) announced that the Central Drugs Standard Control Organisation (CDSCO) has approved an additional indication for Trastuzumab Deruxtecan 100 mg/5 mL vial lyophilized powder for concentrate for solution for infusion, in combination with Pertuzumab as a first-line treatment for adult patients with unresectable or metastatic HER2-positive (IHC 3+ or ISH+) breast cancer. In India, HER2-positive breast […]
Article by: IMT News Desk